Centiva Capital’s Exelon EXC Stock Holding History

Centiva Capital’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,000	Closed	-$113K	–	1725
2024 Q4	$113K	Sell	3,000 -7,000	-70%	-$272K	﹤0.01%	1483
2024 Q3	$406K	Buy	+10,000	New	+$376K	0.01%	1396
2022 Q3	–	Sell	-5,000	Closed	-$227K	–	1598
2022 Q2	$227K	Hold	5,000	–	–	0.01%	1238
2022 Q1	$238K	Buy	+5,000	New	+$212K	﹤0.01%	1234

Other funds holding EXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Centiva Capital's EXC Position: Q2 2026 in Review

Centiva Capital sold out of Exelon (EXC) in Q2 2026, closing a stake of 5,600 shares — an estimated $275K sold.

Centiva Capital first reported a position in EXC in Q1 2019 and held it in 14 quarters. The position peaked at $3.83M in Q1 2019. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

Centiva Capital reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 5,600 Exelon shares in Q2 2026, an estimated $275K.
Centiva Capital first reported a position in Exelon in Q1 2019 and held it in 14 quarters.
Centiva Capital's Exelon position peaked at $3.83M in Q1 2019.
1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.